Clinical trial
A Pilot Study to Evaluate Response to Neoadjuvant Chemotherapy With Cisplatin and Docetaxel Followed by Chemoradiation Therapy With Carboplatin in Stage IV Non-metastatic Head and Neck Cancer
NCT00982436 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate Response to Neoadjuvant Chemotherapy With Cisplatin and Docetaxel Followed by Chemoradiation Therapy With Carboplatin in Stage IV Non-metastatic Head and Neck Cancer
- Lead sponsor
- University of Vermont
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2009
- Completion date
- December 31, 2012
- Enrollment
- 37 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.